Previously vaccination against pertussis was not recommended for those over 6 years of age, they add, because of concerns of increased reactogenicity of the whole-cell vaccines.
To test the reactogenicity of the identified epitope, the fusion epitope protein was reacted with anti-IBV serum by ELISA and the fusion epitope protein has good reactivity with anti-IBV serum.